220 related articles for article (PubMed ID: 18552710)
1. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants.
Mohan R; Koebnick C; Schildt J; Mueller M; Radke M; Blaut M
Pediatr Res; 2008 Oct; 64(4):418-22. PubMed ID: 18552710
[TBL] [Abstract][Full Text] [Related]
2. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial.
Holscher HD; Czerkies LA; Cekola P; Litov R; Benbow M; Santema S; Alexander DD; Perez V; Sun S; Saavedra JM; Tappenden KA
JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):106S-17S. PubMed ID: 22237870
[TBL] [Abstract][Full Text] [Related]
3. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study.
Mohan R; Koebnick C; Schildt J; Schmidt S; Mueller M; Possner M; Radke M; Blaut M
J Clin Microbiol; 2006 Nov; 44(11):4025-31. PubMed ID: 16971641
[TBL] [Abstract][Full Text] [Related]
4. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial.
Rougé C; Piloquet H; Butel MJ; Berger B; Rochat F; Ferraris L; Des Robert C; Legrand A; de la Cochetière MF; N'Guyen JM; Vodovar M; Voyer M; Darmaun D; Rozé JC
Am J Clin Nutr; 2009 Jun; 89(6):1828-35. PubMed ID: 19369375
[TBL] [Abstract][Full Text] [Related]
5. Effect of neutral and acidic oligosaccharides on fecal IL-8 and fecal calprotectin in preterm infants.
Westerbeek EA; Mørch E; Lafeber HN; Fetter WP; Twisk JW; Van Elburg RM
Pediatr Res; 2011 Mar; 69(3):255-8. PubMed ID: 21228732
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants.
Wang C; Shoji H; Sato H; Nagata S; Ohtsuka Y; Shimizu T; Yamashiro Y
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):252-7. PubMed ID: 17255840
[TBL] [Abstract][Full Text] [Related]
7. Probiotics and growth in preterm infants: A randomized controlled trial, PREMAPRO study.
Hays S; Jacquot A; Gauthier H; Kempf C; Beissel A; Pidoux O; Jumas-Bilak E; Decullier E; Lachambre E; Beck L; Cambonie G; Putet G; Claris O; Picaud JC
Clin Nutr; 2016 Aug; 35(4):802-11. PubMed ID: 26220763
[TBL] [Abstract][Full Text] [Related]
8. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial.
Kim JY; Kwon JH; Ahn SH; Lee SI; Han YS; Choi YO; Lee SY; Ahn KM; Ji GE
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e386-93. PubMed ID: 19840300
[TBL] [Abstract][Full Text] [Related]
9. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
[TBL] [Abstract][Full Text] [Related]
10. Probiotic supplementation in mothers of very low birth weight infants.
Benor S; Marom R; Ben Tov A; Armoni Domany K; Zaidenberg-Israeli G; Dollberg S
Am J Perinatol; 2014 Jun; 31(6):497-504. PubMed ID: 23934538
[TBL] [Abstract][Full Text] [Related]
11. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
12. A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA.
Campeotto F; Suau A; Kapel N; Magne F; Viallon V; Ferraris L; Waligora-Dupriet AJ; Soulaines P; Leroux B; Kalach N; Dupont C; Butel MJ
Br J Nutr; 2011 Jun; 105(12):1843-51. PubMed ID: 21426607
[TBL] [Abstract][Full Text] [Related]
13. Consumption of Bifidobacterium lactis LKM512 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects.
Matsumoto M; Benno Y
Mutat Res; 2004 Dec; 568(2):147-53. PubMed ID: 15542102
[TBL] [Abstract][Full Text] [Related]
14. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial.
Mihatsch WA; Vossbeck S; Eikmanns B; Hoegel J; Pohlandt F
Neonatology; 2010; 98(2):156-63. PubMed ID: 20234140
[TBL] [Abstract][Full Text] [Related]
15. The effect of Bifidobacterium lactis on the growth of infants: a pooled analysis of randomized controlled studies.
Steenhout PG; Rochat F; Hager C
Ann Nutr Metab; 2009; 55(4):334-40. PubMed ID: 19844090
[TBL] [Abstract][Full Text] [Related]
16. [Fecal calprotectin levels in preterm infants during the early neonatal period].
Cui X; Li J
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):165-8. PubMed ID: 22433399
[TBL] [Abstract][Full Text] [Related]
17. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial.
Lin HC; Hsu CH; Chen HL; Chung MY; Hsu JF; Lien RI; Tsao LY; Chen CH; Su BH
Pediatrics; 2008 Oct; 122(4):693-700. PubMed ID: 18829790
[TBL] [Abstract][Full Text] [Related]
18. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis.
Fallahi G; Motamed F; Yousefi A; Shafieyoun A; Najafi M; Khodadad A; Farhmand F; Ahmadvand A; Rezaei N
Turk J Pediatr; 2013; 55(5):475-8. PubMed ID: 24382526
[TBL] [Abstract][Full Text] [Related]
19. Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials.
Szajewska H; Guandalini S; Morelli L; Van Goudoever JB; Walker A
J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):203-9. PubMed ID: 20543719
[TBL] [Abstract][Full Text] [Related]
20. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials.
Wang Q; Dong J; Zhu Y
J Pediatr Surg; 2012 Jan; 47(1):241-8. PubMed ID: 22244424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
